Latest News
Notice of Amendment - Title 27, California Code of Regulations Amendment of Section 25703(a)(6): Quantitative Risk Assessment. The amendment modifies the calculation used to convert estimates of animal cancer potency to estimates of human cancer potency, which is used to calculate no significant risk levels for carcinogens listed under Proposition 65.
| Program: Proposition 65
OEHHA has selected the chemicals below for the CIC’s review for possible listing under Proposition 65. OEHHA is initiating the development of hazard identification materials on C.I. Disperse Yellow 3, Dibenzanthracenes and dibenz[a,c]anthracene.
| Program: Proposition 65
OEHHA posted the external peer review comments on the draft Public Health Goal for perchlorate in drinking water.
| Program: Water
OEHHA released for public comment the Air Toxics "Hot Spots" Program Risk Assessment Guidelines: Technical Support Document for Exposure Assessment and Stochastic Analysis.
| Program: Air
On September 23, 2011, OEHHA published a notice in the California Regulatory Notice Register (Register 2011, No.
| Program: Proposition 65
Estrogen–progestogen (combined) used as menopausal therapy, etoposide, etoposide in combination with cisplatin and bleomycin, methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) listed as known to cause cancer under Proposition 65.
| Program: Proposition 65
Meeting Synopsis and Slide Presentations Carcinogen Identification Committee Meeting Held on October 12, 2011
| Program: Proposition 65
Extension of public comment period regarding the removal of the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested.
| Program: Proposition 65
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) was listed effective 10/28/2011 as known to the State to cause cancer.
| Program: Proposition 65
Extension of comment period regarding the establishment of a specific regulatory level posing no significant risk for Imazalil.
| Program: Proposition 65